Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
46.3K
-
Shares change
-
+46.3K
-
Total reported value, excl. options
-
$400K
-
Value change
-
+$400K
-
Number of buys
-
15
-
Price
-
$8.64
Significant Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q1 2025
16 filings reported holding INKT - MiNK Therapeutics, Inc. - COM NEW as of Q1 2025.
MiNK Therapeutics, Inc. - COM NEW (INKT) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (23.7K shares), GEODE CAPITAL MANAGEMENT, LLC (11.3K shares), BlackRock, Inc. (8.78K shares), WELLS FARGO & COMPANY/MN (848 shares), BANK OF AMERICA CORP /DE/ (757 shares), UBS Group AG (284 shares), OSAIC HOLDINGS, INC. (238 shares), Tower Research Capital LLC (TRC) (172 shares), Covestor Ltd (104 shares), and JPMORGAN CHASE & CO (30 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.